3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
2
Phase NA
1
Status
Completed
2
Recruiting
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
1
Breast
1
Conditions
Breast Neoplasms
134
Neoplasms
112
Polycystic Ovary Syndrome
66
Prostatic Neoplasms
63
Colorectal Neoplasms
51
Carcinoma, Non-Small-Cell Lung
46
Pain
40
Carcinoma, Hepatocellular
35
Lung Neoplasms
34
Keratosis, Actinic
32
Precursor Cell Lymphoblastic Leukemia-Lymphoma
29
Neoplasm Metastasis
26
Head and Neck Neoplasms
26
Pain, Postoperative
25
Stomach Neoplasms
24
Colonic Neoplasms
23
Multiple Myeloma
22
Brain Neoplasms
21
Pancreatic Neoplasms
20
Lymphoma, Follicular
19
Leukemia
19
Anemia
19
Uterine Cervical Neoplasms
18
Leukemia, Myeloid, Acute
18
Infertility
18
Leiomyoma
17
Lymphoma, Non-Hodgkin
16
Lymphoma
16
Cancer Pain
16
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
15
Interventions
Dexamethasone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 4
×
Completed
×
Systemic Inflammatory Response Syndrome
×
Clear all
NCT03125941
2019-12-02
DEX-MAS
Rigshospitalet, Denmark
Phase 4
Completed
130 enrolled
20 charts
NCT02728921
2017-04-19
AIR
Region Skane
Phase 4
Completed
70 enrolled